Evaluate the safety of three 8-week courses of treatment with LIPO-202 in non-obese patients who have central abdominal bulging. Efficacy measurements will also be collected.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
150
AboutSkin Dermatology
Englewood, Colorado, United States
Dermatology Research Institute, LLC
Coral Gables, Florida, United States
Gwinnett Clinical Research Center, Inc
Snellville, Georgia, United States
Lupo Center for Aesthetic and General Dermatology
Safety: vital signs, physical exams, laboratory tests
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
New Orleans, Louisiana, United States
Bass Plastic Surgery PLLC
New York, New York, United States
DermResearch Center of New York
Stony Brook, New York, United States
Dermatology Clinical Research Center of San Antonio
San Antonio, Texas, United States
Charlottesville Medical Research
Charlottesville, Virginia, United States